180 related articles for article (PubMed ID: 10344635)
1. Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
Rainsford KD
J Pharm Pharmacol; 1999 Mar; 51(3):331-9. PubMed ID: 10344635
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.
Vaananen PM; Keenan CM; Grisham MB; Wallace JL
Inflammation; 1992 Jun; 16(3):227-40. PubMed ID: 1323529
[TBL] [Abstract][Full Text] [Related]
3. Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat.
Gyömber E; Vattay P; Szabo S; Rainsford KD
J Gastroenterol Hepatol; 1996 Oct; 11(10):922-7. PubMed ID: 8912128
[TBL] [Abstract][Full Text] [Related]
4. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651
[TBL] [Abstract][Full Text] [Related]
5. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
Konturek SJ; Brzozowski T; Drozdowicz D; Garlicki J; Beck G
Eur J Pharmacol; 1989 May; 164(2):285-92. PubMed ID: 2759176
[TBL] [Abstract][Full Text] [Related]
6. Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage.
Rainsford KD
Agents Actions; 1993; 39 Spec No():C24-6. PubMed ID: 8273575
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
8. Investigations of indomethacin-induced gastric ulcer in rats.
Kapui Z; Boér K; Rózsa I; Blaskó G; Hermecz I
Arzneimittelforschung; 1993 Jul; 43(7):767-71. PubMed ID: 8369011
[TBL] [Abstract][Full Text] [Related]
9. Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro.
Hoffman T; Lee YL; Lizzio EF; Tripathi AK; Jessop JJ; Taplits M; Abrahamsen TG; Carter CS; Puri J
Clin Immunol Immunopathol; 1991 Mar; 58(3):399-408. PubMed ID: 1900463
[TBL] [Abstract][Full Text] [Related]
10. Role of leukotriene C4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach.
Peskar BM
Gastroenterology; 1991 Mar; 100(3):619-26. PubMed ID: 1993484
[TBL] [Abstract][Full Text] [Related]
11. Chronic leukotriene inhibition in the rat fails to modify the toxicological effects of a cyclooxygenase inhibitor.
Ford-Hutchinson AW; Tagari P; Ching SV; Anderson CA; Coleman JB; Peter CP
Can J Physiol Pharmacol; 1993; 71(10-11):806-10. PubMed ID: 8143238
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
13. The role of platelet activating factor [correction of actor] in acute gastric injury and its protection by sucralfate.
Ligumsky M; Sestieri M; Karmeli F; Okon E; Rachmilewitz D
Aliment Pharmacol Ther; 1990 Oct; 4(5):507-14. PubMed ID: 2129638
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in mice.
Nakamori Y; Komatsu Y; Kotani T; Kojima S; Takeuchi K
J Pharmacol Exp Ther; 2010 Apr; 333(1):91-8. PubMed ID: 20042530
[TBL] [Abstract][Full Text] [Related]
15. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
Karmeli F; Eliakim R; Okon E; Rachmilewitz D
Gastroenterology; 1991 May; 100(5 Pt 1):1206-16. PubMed ID: 1707383
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of 5-lipoxygenase metabolite in itch-associated response of mosquito allergy in mice.
Kuraishi Y; Ohtsuka E; Nakano T; Kawai S; Andoh T; Nojima H; Kamimura K
J Pharmacol Sci; 2007 Sep; 105(1):41-7. PubMed ID: 17827870
[TBL] [Abstract][Full Text] [Related]
17. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of small intestine to NSAID-provoked ulceration in rats with adjuvant-induced arthritis: involvement of enhanced expression of TLR4.
Kato S; Ito Y; Nishio H; Aoi Y; Amagase K; Takeuchi K
Life Sci; 2007 Sep; 81(16):1309-16. PubMed ID: 17920637
[TBL] [Abstract][Full Text] [Related]
19. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.
Gillard J; Ford-Hutchinson AW; Chan C; Charleson S; Denis D; Foster A; Fortin R; Leger S; McFarlane CS; Morton H
Can J Physiol Pharmacol; 1989 May; 67(5):456-64. PubMed ID: 2548691
[TBL] [Abstract][Full Text] [Related]
20. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.
Boughton-Smith NK; Whittle BJ
Br J Pharmacol; 1988 Sep; 95(1):155-62. PubMed ID: 3146394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
